Literature DB >> 12177048

Promoter-specific activation and demethylation by MBD2/demethylase.

Nancy Detich1, Johanne Theberge, Moshe Szyf.   

Abstract

MBD2 is the only member of a family of methyl-CpG-binding proteins that has been reported to be both a transcriptional repressor and a DNA demethylase (dMTase). To understand the apparently contradictory function of MBD2/dMTase, we studied the effects of dMTase overexpression on the activity of various in vitro methylated promoters transiently transfected into HEK293 cells. We found that forced expression of a MBD2/dMTase expression vector (His-dMTase) differentially activated two methylated reporters, pSV40-CAT (the SV40 enhancerless promoter adjacent to the chloramphenicol acetyltransferase (CAT) reporter gene) and pGL2T+I4xTBRE (a region of the p21 promoter next to the luciferase reporter gene), in a time- and dose-dependent manner. His-dMTase increased pSV40-CAT expression by 3-10-fold after 96 h, while pGL2T+I4xTBRE expression was increased by 2-3-fold after only 48 h and did not further increase at 96 h. Gene activation was not universal because no effect was seen with the p19-ARF promoter. We then assessed whether activation might be due to demethylation within the promoter region. Using bisulfite mapping, we found that exogenous expression of His-dMTase induced demethylation at 8 of the 10 CpG sites within the SV40 promoter. The observation that His-dMTase increases the demethylase activity in the cells was also confirmed using an in vitro CpG demethylase assay with a mC32pG oligonucleotide substrate and purified Q-Sepharose fractions from HEK293 cells transfected with His-dMTase or empty pcDNA3.1His vector. We propose that a single protein possessing both repressor and demethylase functions has evolved to coordinate a program that requires suppression of some methylated genes and activation of others.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177048     DOI: 10.1074/jbc.C200408200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Epigenetic programming of the rRNA promoter by MBD3.

Authors:  Shelley E Brown; Moshe Szyf
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

3.  Epigenetics in mood disorders.

Authors:  Patrick O McGowan; Tadafumi Kato
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

4.  Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma.

Authors:  Xu You Liu; Shao Hui Tang; Sheng Lan Wu; Yu Hong Luo; Ming Rong Cao; Hong Ke Zhou; Xiang Wu Jiang; Jian Chang Shu; Cai Qun Bie; Si Min Huang; Zhan Hong Zheng; Fei Gao
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

5.  The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation.

Authors:  Moshe Szyf
Journal:  Toxicol Sci       Date:  2011-02-04       Impact factor: 4.849

Review 6.  Epigenetic underpinnings of developmental sex differences in the brain.

Authors:  Bridget M Nugent; Margaret M McCarthy
Journal:  Neuroendocrinology       Date:  2011-03-11       Impact factor: 4.914

Review 7.  Epigenetic reprogramming: is deamination key to active DNA demethylation?

Authors:  Marta Teperek-Tkacz; Vincent Pasque; George Gentsch; Anne C Ferguson-Smith
Journal:  Reproduction       Date:  2011-09-12       Impact factor: 3.906

Review 8.  Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale?

Authors:  Graham C Burdge; Karen A Lillycrop; Alan A Jackson
Journal:  Br J Nutr       Date:  2008-12-12       Impact factor: 3.718

Review 9.  DNA methylation of cancer genome.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-12

10.  Enhanced gene targeting frequency in ES cells with low genomic methylation levels.

Authors:  Juan Domínguez-Bendala; Jim McWhir
Journal:  Transgenic Res       Date:  2004-02       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.